CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

CellCarta Adds Tempus to CDx Commercialization Lab Network

PartnershipPositive
AI Analysis

Summary

CellCarta announced that Tempus has joined as a second commercial laboratory partnership to support oncology-focused companion diagnostic access within CellCarta's CDx Accelerator Model.

Importance:5/10
Sentiment:
0.60
partnershipcommercializationCDxoncologylaboratory
Related Companies

Read the original article

Published by PR Newswire Pharma on August 6, 2026 1:15 PM

Read Original